Maven Securities LTD Neurocrine Biosciences Inc Transaction History

Maven Securities LTD

  • $585 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$86.8 - $118.57 $945,252 - $1.29 Million
-10,890 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$83.82 - $101.5 $912,799 - $1.11 Million
10,890 New
10,890 $979,000
Q4 2018

Feb 14, 2019
SELL
$68.32 - $124.36 $455,831 - $829,729
-6,672 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$98.88 - $125.85 $659,727 - $839,671
6,672 New
6,672 $822,000

Others Institutions Holding NBIX

# of Institutions
641
Shares Held
95.2M
Call Options Held
661K
Put Options Held
227K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $10.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email